Global Electroporation Instruments Market 2018-2022| Rising Demand for Monoclonal Antibodies to Boost Demand| Technavio
LONDON--(BUSINESS WIRE)--Oct 1, 2018-- analysts forecast the global electroporation instruments market to grow at a CAGR of close to 6% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181001005549/en/
Technavio analysts forecast the global electroporation instruments market to grow at a CAGR of close to 6% by 2022 (Graphic: Business Wire)
The high demand for biopharmaceuticals is one of the major trends being witnessed in the . Biopharmaceuticals are manufactured or extracted from biological sources. Some biopharmaceuticals include vaccines, blood components, allergens, stem cells, tissues, gene therapies, antibodies, and recombinant therapeutic protein and living cells, which are used for therapeutic purposes. They also include regenerative medicine in which tissue or part of the organ is replaced with the help of stem cells in patients suffering from severe chronic diseases.
According to Technavio analysts, one of the key factors contributing to the growth of the global electroporation instruments market is the rising demand for monoclonal antibodies:
Global electroporation instruments market: Rising demand for monoclonal antibodies
Monoclonal antibodies are identical immune cells and are one of the fastest growing products in the pharmaceutical industry. They have a wide array of applications in the fields of biology, diagnostic imaging, medicine, and biochemistry. Some of the medical applications include areas related to cancer, multiple sclerosis, rheumatoid arthritis, cardiovascular diseases, Crohn’s disease, psoriasis, and ulcerative colitis. The increase in demand for monoclonal antibodies has triggered the development of new technologies for their production.
According to a senior analyst at Technavio for research on life science research tools, “Large manufacturers have built large-scale manufacturing plants containing multiple cell culture bioreactors for antibody production. For instance, Thermo Fisher Scientific also manufactures monoclonal antibodies, which involve stable cell lines, cell culture expansion, downstream purification, and final product testing. The company uses advanced electroporation instruments and cell culture media to produce monoclonal antibodies.”
Global electroporation instruments market: Segmentation analysis
The global electroporation instruments market research report provides market segmentation by end-user (pharmaceutical and biotechnology companies, academic and research institutes, and CROs), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Of the three major end-users, the pharmaceutical and biotechnology companies held the largest market share in 2017, contributing to over 46% of the market. This end-user segment will dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2017, accounting for close to 46% share, followed by EMEA and APAC respectively. The growth in the region can be attributed to the advances in biotechnology and pharmaceutical companies.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005549/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 10/01/2018 10:01 AM/DISC: 10/01/2018 10:01 AM